by Brook White | Nov 30, 2020 | Blog
This blog series shares what’s happening day-to-day in our Innovation Lab. VeraSci created the Innovation Lab to pair scientific knowledge with cutting-edge technology to improve the tools and measurements available for clinical trials. We originally presented these... by Brook White | Nov 10, 2020 | Blog
Dr. Luca Pani is the former Director General of the Italian Medicines Agency and a former member of the Board of Directors of the Committee for Human Medicines (CHMP) and of the Scientific Advice Working Party (SAWP) for the European Medicines Agency (EMA) in London.... by Brook White | Nov 5, 2020 | Posters
Presented at the Clinical Trials on Alzheimer’s Disease (CTAD) Digital Event, November 4-7, 2020 Integration of wearable devices into regulated clinical trials for the assessment of cognition and function continues to be a topic of growing interest. If... by Brook White | Oct 5, 2020 | Blog
One of the most frequently used assessments in clinical trials of Parkinson’s Disease is the Movement Disorders Society version of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS). Producing high-quality data is crucial for demonstrating efficacy for new... by Brook White | Sep 23, 2020 | Blog
In a recent article published in Neurology, the Dementia with Lewy Bodies (DLB) Consortium published new consensus research criteria for prodromal DLB, or DLB prior to the onset of dementia. These new criteria have the potential to significantly impact clinical trials...